Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Apr 4;395(10230):1111.
doi: 10.1016/S0140-6736(20)30691-7. Epub 2020 Mar 24.

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?

Andrew I Ritchie  1 , Aran Singanayagam  2
Affiliations
Comment

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?

Andrew I Ritchie et al. Lancet. .
No abstract available

PubMed Disclaimer

Comment on

  • COVID-19: consider cytokine storm syndromes and immunosuppression.
    Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. Mehta P, et al. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16. Lancet. 2020. PMID: 32192578 Free PMC article. No abstract available.

References

    1. Mehta PM, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 doi: 10.1016/S0140-6736(20)30628-0. published online March 16. - DOI - PMC - PubMed
    1. Lee N, Chan MC, Lui GC. High viral load and respiratory failure in adults hospitalized for respiratory syncytial virus infections. J Infect Dis. 2015;212:1237–1240. - PMC - PubMed
    1. Singanayagam A, Glanville N, Girkin JL. Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations. Nat Commun. 2018;9 - PMC - PubMed
    1. Thomas BJ, Porritt RA, Hertzog PJ, Bardin PG, Tate MD. Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon. Sci Rep. 2014;4 - PMC - PubMed
    1. Boor PPC, de Ruiter PE, Asmawidjaja PS, Lubberts E, van der Laan LJW, Kwekkeboom J. JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa. Transl Res. 2017;188:67–79. - PubMed